Shelf life (days): 730.0
Formulation: A solution in ethanol
Formal Name: (5Z)-7-[(1R,2R,3R,5S)-2-[(1E)-3,3-difluoro-4-phenoxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-5-heptenoic acid, 1-methylethyl ester
Purity: ≥98%
Formula Markup: C25H34F2O5
Formula Weight: 452.5
CAS Number: 209860-87-7
Notes: Tafluprost is a prodrug form of the FP receptor agonist tafluprost (free acid) (Item No. 10005439) and a derivative of prostaglandin F2α (PGF2α; Item Nos. 16010 / 16020).{11598} It decreases pupillary diameter in cats when applied topically at doses of 0.0001 or 0.001% v/v. Ocular administration of tafluprost (0.0005% v/v) reduces intraocular pressure in normotensive monkeys. Formulations containing tafluprost have been used in the treatment of open-angle glaucoma and ocular hypertension.